Insulet Corporation (PODD)

NASDAQ
227.73
+8.76(+4.00%)
After Hours
227.04
-0.69(-0.30%)
- Real-time Data
  • Volume:
    378,002
  • Day's Range:
    218.00 - 227.96
  • 52 wk Range:
    181.00 - 324.81

PODD Overview

Prev. Close
218.97
Day's Range
218-227.96
Revenue
1.14B
Open
218
52 wk Range
181-324.81
EPS
0.61
Volume
378,002
Market Cap
15.79B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
527,607
P/E Ratio
375.63
Beta
0.69
1-Year Change
-17.8%
Shares Outstanding
69,339,638
Next Earnings Date
03 Aug 2022
What is your sentiment on Insulet?
or
Market is currently closed. Voting is open during market hours.

Insulet Corporation Company Profile

Insulet Corporation Company Profile

Insulet Corporation is primarily engaged in the development, manufacture and sale of its Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyNeutral
Technical IndicatorsStrong BuyBuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuySell